# Tranexamic Acid for Blood Loss Minimization in Endoscopic Pituitary Surgery

> **NCT04863339** · PHASE2 · WITHDRAWN · sponsor: **University of North Carolina, Chapel Hill**

## Conditions studied

- Pituitary Tumor
- Blood Loss
- Surgery

## Interventions

- **DRUG:** Tranexamic acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04863339
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-03
- **Primary completion:** 2022-04
- **Final completion:** 2022-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Challenges in recruitment
- **Last updated:** 2022-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04863339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04863339, "Tranexamic Acid for Blood Loss Minimization in Endoscopic Pituitary Surgery". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT04863339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*